The long journey of botulinum neurotoxins into the synapse.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Toxicon

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.toxicon.2015.09.009PMID 26363288
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin.

  2016cited by this paper
• Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity

  2015cited by this paper
• Architecture of the botulinum neurotoxin complex: a molecular machine for protection and delivery.

  2015cited by this paper
• Clostridium botulinum Group II Isolate Phylogenomic Profiling Using Whole-Genome Sequence Data

  2015cited by this paper
• Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.

  2015cited by this paper
• Genomic sequences of six botulinum neurotoxin-producing strains representing three clostridial species illustrate the mobility and diversity of botulinum neurotoxin genes.

  2015cited by this paper
• Comparison of Systemic Toxicity between Botulinum Toxin Subtypes A1 and A2 in Mice and Rats

  2015cited by this paper
• Isolation and Functional Characterization of the Novel Clostridium botulinum Neurotoxin A8 Subtype

  2015cited by this paper
• Expression and biochemical characterization of light chains of Botulinum neurotoxin subtypes F5 and F7.

  2015cited by this paper
• Clostridium botulinum type C hemagglutinin affects the morphology and viability of cultured mammalian cells via binding to the ganglioside GM3

  2015cited by this paper
• Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).

  2015cited by this paper
• Plasmidome Interchange between Clostridium botulinum, Clostridium novyi and Clostridium haemolyticum Converts Strains of Independent Lineages into Distinctly Different Pathogens

  2014cited by this paper
• Immunoprecipitation of Native Botulinum Neurotoxin Complexes from Clostridium botulinum Subtype A Strains

  2014cited by this paper
• Structural basis of the pH-dependent assembly of a botulinum neurotoxin complex.

  2014cited by this paper
• Draft Genome Sequence of Bivalent Clostridium botulinum Strain IBCA10-7060, Encoding Botulinum Neurotoxin B and a New FA Mosaic Type

  2014cited by this paper
• Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A

  2014cited by this paper
• Nidogens are therapeutic targets for the prevention of tetanus

  2014cited by this paper
• Molecular Characterization of Clostridium botulinum Isolates from Foodborne Outbreaks in Thailand, 2010

  2014cited by this paper
• Comparison of the immunogenicity of botulinum toxin type A and the efficacy of A1 and A2 neurotoxins in animals with A1 toxin antibodies.

  2014cited by this paper
• High-resolution crystal structure of HA33 of botulinum neurotoxin type B progenitor toxin complex.

  2014cited by this paper
• Positive Regulation of Botulinum Neurotoxin Gene Expression by CodY in Clostridium botulinum ATCC 3502

  2014cited by this paper
• A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.

  2014cited by this paper
• Arrangement of the Clostridium baratii F7 Toxin Gene Cluster with Identification of a σ Factor That Recognizes the Botulinum Toxin Gene Cluster Promoters

  2014cited by this paper
• Persistence of Botulinum Neurotoxin A Subtypes 1-5 in Primary Rat Spinal Cord Cells

  2014cited by this paper
• Functional Dissection of the Clostridium botulinum Type B Hemagglutinin Complex: Identification of the Carbohydrate and E-Cadherin Binding Sites

  2014cited by this paper
• Whole-Genome Single-Nucleotide-Polymorphism Analysis for Discrimination of Clostridium botulinum Group I Strains

  2014cited by this paper
• Botulinum neurotoxins: genetic, structural and mechanistic insights

  2014cited by this paper
• Botulinum Neurotoxin A Complex Recognizes Host Carbohydrates through Its Hemagglutinin Component

  2014cited by this paper
• Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins.

  2014cited by this paper
• Genome Sequence of the Neurotoxigenic Clostridium butyricum Strain 5521

  2014cited by this paper
• Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex

  2014cited by this paper
• Molecular characterization of a novel botulinum neurotoxin type H gene.

  2014cited by this paper
• Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System

  2014cited by this paper
• Two Novel Toxin Variants Revealed by Whole-Genome Sequencing of 175 Clostridium botulinum Type E Strains

  2014cited by this paper
• Cytotoxicity of Botulinum Neurotoxins Reveals a Direct Role of Syntaxin 1 and SNAP-25 in Neuron Survival

  2013cited by this paper
• Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A

  2013cited by this paper
• Two-Component Signal Transduction System CBO0787/CBO0786 Represses Transcription from Botulinum Neurotoxin Promoters in Clostridium botulinum ATCC 3502

  2013cited by this paper
• Synchronized chaperone function of botulinum neurotoxin domains mediates light chain translocation into neurons.

  2013cited by this paper
• Crystal Structure of Clostridium botulinum Whole Hemagglutinin Reveals a Huge Triskelion-shaped Molecular Complex*

  2013cited by this paper
• The Type F6 Neurotoxin Gene Cluster Locus of Group II Clostridium botulinum Has Evolved by Successive Disruption of Two Different Ancestral Precursors

  2013cited by this paper
• Improved detection methods by genetic and immunological techniques for botulinum C/D and D/C mosaic neurotoxins.

  2013cited by this paper
• Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.

  2013cited by this paper
• Molecular assembly of botulinum neurotoxin progenitor complexes

  2013cited by this paper
• Regulation of toxin synthesis in Clostridium botulinum and Clostridium tetani.

  2013cited by this paper
• Characterization of Botulinum Neurotoxin A Subtypes 1 Through 5 by Investigation of Activities in Mice, in Neuronal Cell Cultures, and In Vitro

  2013cited by this paper
• Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.

  2013cited by this paper
• Structure of a Bimodular Botulinum Neurotoxin Complex Provides Insights into Its Oral Toxicity

  2013cited by this paper
• Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.

  2013cited by this paper
• Assembly and function of the botulinum neurotoxin progenitor complex.

  2013cited by this paper
• Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes.

  2013cited by this paper
• Neutralisation of specific surface carboxylates speeds up translocation of botulinum neurotoxin type B enzymatic domain

  2013cited by this paper
• Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E.

  2013cited by this paper
• Synaptic vesicle proteins: targets and routes for botulinum neurotoxins.

  2013cited by this paper
• Structure of dual receptor binding to botulinum neurotoxin B

  2013cited by this paper
• Clostridial neurotoxin light chains: devices for SNARE cleavage mediated blockade of neurotransmission.

  2013cited by this paper
• Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity.

  2013cited by this paper
• Identification of Fibroblast Growth Factor Receptor 3 (FGFR3) as a Protein Receptor for Botulinum Neurotoxin Serotype A (BoNT/A)

  2013cited by this paper
• The elusive compass of clostridial neurotoxins: deciding when and where to go?

  2013cited by this paper
• Clostridium botulinum Strain Af84 Contains Three Neurotoxin Gene Clusters: Bont/A2, bont/F4 and bont/F5

  2013cited by this paper
• Botulinum Neurotoxin Is Shielded by NTNHA in an Interlocked Complex

  2012cited by this paper
• Two-Component Systems Are Involved in the Regulation of Botulinum Neurotoxin Synthesis in Clostridium botulinum Type A Strain Hall

  2012cited by this paper
• Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins

  2012cited by this paper
• Botulinum Neurotoxin Serotype C Associates with Dual Ganglioside Receptors to Facilitate Cell Entry*

  2012cited by this paper
• Analysis of a unique Clostridium botulinum strain from the Southern hemisphere producing a novel type E botulinum neurotoxin subtype

  2012cited by this paper
• Preferential Entry of Botulinum Neurotoxin A Hc Domain through Intestinal Crypt Cells and Targeting to Cholinergic Neurons of the Mouse Intestine

  2012cited by this paper
• De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics

  2012cited by this paper
• Human synaptotagmin‐II is not a high affinity receptor for botulinum neurotoxin B and G: Increased therapeutic dosage and immunogenicity

  2012cited by this paper
• Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5

  2012cited by this paper
• Carbohydrate recognition mechanism of HA70 from Clostridium botulinum deduced from X‐ray structures in complexes with sialylated oligosaccharides

  2012cited by this paper
• Crystal structure of the receptor binding domain of the botulinum C-D mosaic neurotoxin reveals potential roles of lysines 1118 and 1136 in membrane interactions.

  2011cited by this paper
• Horizontal gene transfer of toxin genes in Clostridium botulinum

  2011cited by this paper
• Small RNAs in the Genus Clostridium

  2011cited by this paper
• Molecular diversity of the two sugar-binding sites of the beta-trefoil lectin HA33/C (HA1) from Clostridium botulinum type C neurotoxin

  2011cited by this paper
• The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites

  2011cited by this paper
• Molecular diversity of the two sugar-binding sites of the β-trefoil lectin HA33/C (HA1) from Clostridium botulinum type C neurotoxin.

  2011cited by this paper
• Unique Ganglioside Recognition Strategies for Clostridial Neurotoxins*

  2011cited by this paper
• Beltless Translocation Domain of Botulinum Neurotoxin A Embodies a Minimum Ion-conductive Channel*

  2011cited by this paper
• Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test.

  2011cited by this paper
• Analysis of Clostridium botulinum Serotype E Strains by Using Multilocus Sequence Typing, Amplified Fragment Length Polymorphism, Variable-Number Tandem-Repeat Analysis, and Botulinum Neurotoxin Gene Sequencing

  2011cited by this paper
• Botulinum Neurotoxin D Uses Synaptic Vesicle Protein SV2 and Gangliosides as Receptors

  2011cited by this paper
• Clostridium botulinum group III: a group with dual identity shaped by plasmids, phages and mobile elements

  2011cited by this paper
• Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.

  2010cited by this paper
• Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin

  2010cited by this paper
• SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons

  2010cited by this paper
• SV2 regulates neurotransmitter release via multiple mechanisms.

  2010cited by this paper
• Novel Structural Elements within the Nonproteolytic Clostridium botulinum Type F Toxin Gene Cluster

  2010cited by this paper
• Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA .

  2010cited by this paper
• Type C botulinum toxin causes degeneration of motoneurons in vivo

  2010cited by this paper
• Characterization of Botulinum Neurotoxin Type A Neutralizing Monoclonal Antibodies and Influence of Their Half-Lives on Therapeutic Activity

  2010cited by this paper
• Different Substrate Recognition Requirements for Cleavage of Synaptobrevin-2 by Clostridium baratii and Clostridium botulinum Type F Neurotoxins

  2010cited by this paper
• Botulinum neurotoxin: a marvel of protein design.

  2010cited by this paper
• Cotrafficking of SV2 and Synaptotagmin at the Synapse

  2010cited by this paper
• Regulation of Neurotoxin Production and Sporulation by a Putative agrBD Signaling System in Proteolytic Clostridium botulinum

  2010cited by this paper
• Sequence Diversity of Genes Encoding Botulinum Neurotoxin Type F

  2010cited by this paper
• Neurotoxin Gene Clusters in Clostridium botulinum Type Ab Strains

  2009cited by this paper
• Receptor and substrate interactions of clostridial neurotoxins.

  2009cited by this paper
• Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3.

  2009cited by this paper
• Expression and stability of the nontoxic component of the botulinum toxin complex.

  2009cited by this paper
• Catalytic properties of botulinum neurotoxin subtypes A3 and A4.

  2009cited by this paper
• Crystal structure of the HA3 subcomponent of Clostridium botulinum type C progenitor toxin.

  2009cited by this paper

• Updates on the Proposed Botulinum Toxin A Mechanisms of Action in Orofacial Pain: A Review of Animal Studies

  2025cites this paper
• Foodborne Botulism Caused by Clostridium botulinum Subtype A5(b3) by Self-Packaged Vacuum Spicy Rabbit Heads

  2025cites this paper
• Infant Botulism and Carbohydrate Blood Group Antigens: Preliminary Results from a Discordant Twin Study

  2025cites this paper
• Factors affecting the effectiveness of intravesical injection of botulinum toxin A in females with overactive bladder

  2024cites this paper
• Intramuscular Botulinum Neurotoxin Serotypes E and A Elicit Distinct Effects on SNAP25 Protein Fragments, Muscular Histology, Spread and Neuronal Transport: An Integrated Histology-Based Study in the Rat

  2024cites this paper
• RETRACTED ARTICLE: SERS-Based Rapid Detection of Botulinum Toxin A Using an Aptasensor

  2024cites this paper
• Rapid detection of A-type botulinum toxin using an aptasensor and SERS

  2024cites this paper
• Botulinum Toxin-A Infiltration to Control Post-Operative Pain after Mastectomy and Expander Reconstruction as Potentially Useful Tool: A Narrative Review

  2024cites this paper
• Safety and efficacy of intralesional bleomycin for keloids and hypertrophic scars: A systematic review and meta‐analysis

  2024cites this paper
• Rapid SERS Detection of Botulinum Neurotoxin Type A

  2023cites this paper
• Use of botulinum toxin in aesthetic medicine and gynaecology: current approaches, controversies, and future directions

  2023cites this paper
• Mechanism and clinical use of botulinum neurotoxin in head and facial region.

  2023cites this paper
• Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches

  2022cites this paper
• How Botulinum Neurotoxin Light Chain A1 Maintains Stable Association with the Intracellular Neuronal Plasma Membrane

  2022cites this paper
• Clinical Onset of Action of Incobotulinum Toxin A Preparation.

  2022cites this paper
• Elucidation of critical pH-dependent structural changes in Botulinum Neurotoxin E.

  2022cites this paper
• Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update

  2022cites this paper
• Diverse Phage-Encoded Toxins and Their Role in Bacterial Ecology

  2022cites this paper
• Botulinum Toxin for Neurogenic and Non-neurogenic Bladder Pain

  2022cites this paper
• Plasma Metabolomic Changes in Children with Cerebral Palsy Exposed to Botulinum Neurotoxin.

  2022cites this paper
• Crystal Structures of the Clostridium botulinum Neurotoxin A6 Cell Binding Domain Alone and in Complex with GD1a Reveal Significant Conformational Flexibility

  2022cites this paper
• hiPSC-Derived Neurons Provide a Robust and Physiologically Relevant In Vitro Platform to Test Botulinum Neurotoxins

  2021cites this paper
• Trigonal-Sparing vs. Trigonal-Involved OnabotulinumtoxinA Injection for the Treatment of Overactive Bladder: A Systematic Review and Meta-Analysis

  2021cites this paper
• Delivery of single-domain antibodies into neurons using a chimeric toxin–based platform is therapeutic in mouse models of botulism

  2021cites this paper
• Neuron-recognizable characteristics of peptides recombined using a neuronal binding domain of botulinum neurotoxin

  2021cites this paper
• The posterior cranial fossa's dura mater innervation and its clinical implication in headache: a comprehensive review.

  2021cites this paper
• Knockin mouse models demonstrate differential contributions of synaptotagmin-1 and -2 as receptors for botulinum neurotoxins

  2021cites this paper
• Pan-Genomic Analysis of Clostridium botulinum Group II (Non-Proteolytic C. botulinum) Associated with Foodborne Botulism and Isolated from the Environment

  2020cites this paper
• Novel Native and Engineered Botulinum Neurotoxins.

  2020cites this paper
• Effect of Botulinum Toxin A on Bladder Pain—Molecular Evidence and Animal Studies

  2020cites this paper
• Potency and stability of a trivalent, catalytically inactive vaccine against botulinum neurotoxin serotypes C, E and F (triCEF).

  2020cites this paper
• Botulinum toxin as biological warfare agent: poisoning, diagnosis and countermeasures.

  2020cites this paper
• Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy

  2020influential citation
• Inhibition of Clostridium (C.) botulinum and its toxins by probiotic bacteria and their metabolites: An update review

  2020cites this paper
• The 25 kDa HCN Domain of Clostridial Neurotoxins Is Indispensable for Their Neurotoxicity

  2020cites this paper
• Toxemia in Human Naturally Acquired Botulism

  2020cites this paper
• Neurochemical and Neurobiological Weapons.

  2020cites this paper
• Diversity of the Genomes and Neurotoxins of Strains of Clostridium botulinum Group I and Clostridium sporogenes Associated with Foodborne, Infant and Wound Botulism

  2020cites this paper
• The Use of Botulinum Toxin in the Management of Headache Disorders.

  2020cites this paper
• The use of the dynamic weight bearing test to assess the effects of acute, intramuscularly administered botulinum neurotoxin type A1 in rats

  2020cites this paper
• Tetanus Toxin cis-Loop Contributes to Light-Chain Translocation

  2020cites this paper
• How Do Bacterial Neurotoxins Affect Neurosecretion?

  2020cites this paper
• Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study

  2019cites this paper
• Botulinum and Tetanus Neurotoxins.

  2019cites this paper
• Botulinum neurotoxin serotype D - A potential treatment alternative for BoNT/A and B non-responding patients.

  2019cites this paper
• Functional detection of botulinum neurotoxin serotypes A to F by monoclonal neoepitope-specific antibodies and suspension array technology

  2019cites this paper
• Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis

  2019cites this paper
• The role of human serum albumin and neurotoxin associated proteins in the formulation of BoNT/A products.

  2019cites this paper
• SERS-Based Immunoassays for the Detection of Botulinum Toxins A and B Using Magnetic Beads

  2019cites this paper
• Promise and the Pharmacological Mechanism of Botulinum Toxin A in Chronic Prostatitis Syndrome

  2019cites this paper
• Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A–F Employing Taguchi Design-of-Experiments

  2019cites this paper
• Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome—Possible Pathomechanisms and Practical Issues

  2019cites this paper
• Botulinum Toxin: Pharmacology and Injectable Administration for the Treatment of Primary Hyperhidrosis.

  2019cites this paper
• Challenges in the Development of Reference Materials for Protein Toxins

  2019cites this paper
• Functional detection of botulinum neurotoxin serotypes A-F by monoclonal neoepitope-specific antibodies

  2019cites this paper
• Title: Transperineal Intraprostatic Injection of Botox-A versus Transurethral Resection of Prostate for Management of Benign Prostatic Obstruction: A Prospective Randomized Study. Running title: Transperineal Intraprostatic Botox-A for the Management of Benign Prostatic Obstruction

  2019cites this paper
• Discovery of novel bacterial toxins by genomics and computational biology

  2018cites this paper
• 1 A Rapid , Sensitive , and Portable Biosensor Assay for 2 the Detection of Botulinum Neurotoxin Serotype A in 3 Complex Food Matrices 4

  2018cites this paper
• Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6

  2018cites this paper
• The Expanding Therapeutic Utility of Botulinum Neurotoxins

  2018cites this paper
• Botulinum Neurotoxin Diversity from a Gene-Centered View

  2018cites this paper
• Modulation of Intestinal Paracellular Transport by Bacterial Pathogens.

  2018cites this paper
• Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity

  2018influential citation
• Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction

  2018cites this paper
• Botulinum neurotoxin formulations: overcoming the confusion

  2018cites this paper
• A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency

  2018cites this paper
• A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo

  2018cites this paper
• A Rapid, Sensitive, and Portable Biosensor Assay for the Detection of Botulinum Neurotoxin Serotype A in Complex Food Matrices

  2018cites this paper
• Jjj1 Is a Negative Regulator of Pdr1-Mediated Fluconazole Resistance in Candida glabrata

  2018cites this paper
• Engineering of Botulinum Neurotoxins for Biomedical Applications

  2018cites this paper
• Comparative pathogenomics of Clostridium tetani

  2017cites this paper
• The Contribution of Bacteriophages to the Biology and Virulence of Pathogenic Clostridia.

  2017cites this paper
• Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology

  2017cites this paper
• Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature

  2017cites this paper
• Therapeutic Advances in Neurological Disorders

  2017cites this paper
• Changes in caveolin-1, caveolin-3 and vascular endothelial growth factor expression and protein content after botulinum toxin A injection in the right masseter muscle of dystrophin deficient (mdx-) mice.

  2017cites this paper
• BoNT/AB hybrid maintains similar duration of paresis as BoNT/A wild‐type in murine running wheel assay

  2017cites this paper
• Uptake of Clostridial Neurotoxins into Cells and Dissemination.

  2017cites this paper
• Two Feet on the Membrane: Uptake of Clostridial Neurotoxins.

  2017cites this paper
• Hsp90 is involved in the entry of clostridial neurotoxins into the cytosol of nerve terminals

  2017cites this paper
• Reoccurrence of botulinum neurotoxin subtype A3 inducing food-borne botulism, Slovakia, 2015

  2017cites this paper
• Chemical warfare agents. Classes and targets.

  2017cites this paper
• The Molecular Basis of Toxins’ Interactions with Intracellular Signaling via Discrete Portals

  2017cites this paper
• Botulinum Neurotoxin: A Multifunctional Protein for the Development of New Therapeutics

  2017influential citation
• Impact of Clostridium botulinum genomic diversity on food safety

  2016cites this paper
• Stationäre und mobile Verfahren zur Detektion und Differenzierung biologischer Toxine

  2016cites this paper
• Technologies for Detecting Botulinum Neurotoxins in Biological and Environmental Matrices

  2016influential citation
• Vor-Ort-Nachweis bioterroristisch relevanter Agenzien

  2016cites this paper
• Probiotic Microorganisms Inhibit Epithelial Cell Internalization of Botulinum Neurotoxin Serotype A

  2016cites this paper
• Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin

  2016cites this paper
• Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action

  2016cites this paper
• [On-site detection of bioterrorism-relevant agents : Rapid detection methods for viruses, bacteria and toxins - capabilities and limitations].

  2016cites this paper
• Biological toxins of potential bioterrorism risk: Current status of detection and identification technology

  2016cites this paper
• Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain

  2016cites this paper
• Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test

  2015cites this paper